The store will not work correctly when cookies are disabled.
6-Aziridin-1-yl-7-methyl-1,4-dihydro-2H-cyclopenta[b]indole-3,5,8-trione
ID: ALA143527
PubChem CID: 10445119
Max Phase: Preclinical
Molecular Formula: C14H12N2O3
Molecular Weight: 256.26
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC1=C(N2CC2)C(=O)c2[nH]c3c(c2C1=O)CCC3=O
Standard InChI: InChI=1S/C14H12N2O3/c1-6-12(16-4-5-16)14(19)11-9(13(6)18)7-2-3-8(17)10(7)15-11/h15H,2-5H2,1H3
Standard InChI Key: JSNMHIJIQZVMGI-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
6.1875 -6.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1875 -6.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7542 -5.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1500 -6.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6625 -7.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1500 -6.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6625 -5.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1042 -6.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7542 -6.9000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6292 -7.0125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -7.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3292 -7.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6750 -6.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1125 -5.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6625 -7.6125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6625 -5.2125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6792 -5.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1875 -6.5250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6292 -5.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 6 2 0
5 2 1 0
6 7 1 0
7 1 1 0
8 3 2 0
9 2 1 0
10 4 1 0
11 10 1 0
12 10 1 0
13 8 1 0
14 3 1 0
15 5 2 0
16 7 2 0
17 14 1 0
18 13 2 0
19 6 1 0
8 9 1 0
4 5 1 0
17 13 1 0
11 12 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 256.26 | Molecular Weight (Monoisotopic): 256.0848 | AlogP: 1.11 | #Rotatable Bonds: 1 |
Polar Surface Area: 70.01 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.16 | CX Basic pKa: ┄ | CX LogP: 0.16 | CX LogD: -0.19 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.76 | Np Likeness Score: 0.66 |
References
1. Xing C, Wu P, Skibo EB, Dorr RT.. (2000) Design of cancer-specific antitumor agents based on aziridinylcyclopent[b]indoloquinones., 43 (3): [PMID:10669573] [10.1021/jm990466w] |